SEALSQ Corp. ( LAES ) Monday reported its participation as a lead investor in Quobly’s €130 million Series A financing. The round is led by ST Microelectronics ( STM ), SEALSQ, Isalt, and the French Public Investment Bank (BPI France). The SEALSQ investment made via the SEALSQ Quantum Fund supports Quobly’s industrialization of silicon-based quantum processors and the deployment of its first comme...
SEALSQ Corp. ( LAES ) Monday reported its participation as a lead investor in Quobly’s €130 million Series A financing. The round is led by ST Microelectronics ( STM ), SEALSQ, Isalt, and the French Public Investment Bank (BPI France). The SEALSQ investment made via the SEALSQ Quantum Fund supports Quobly’s industrialization of silicon-based quantum processors and the deployment of its first commercial systems. It strengthens the strategic technical partnership initiated in November 2025 and represents a major milestone in the execution of SEALSQ’s Quantum Vertical Sovereign Stack strategy. As part of this investment, Carlos Moreira , CEO of SEALSQ, will join Quobly’s Board of Directors. More on SEALSQ Sealsq: Quantum Growth Setup With Cash-Backed Undervaluation SEALSQ Corp (LAES) Q4 2025 Earnings Call Transcript Sealsq: The New Share Offering Will Strengthen The Balance Sheet Even More SEALSQ buys Miraex to expand quantum solutions Quantum computing stocks to extend rally as federal backing tests bearish sentiment
ljubaphoto/E+ via Getty Images Shares of Globus Medical ( GMED ) have been trading flattish in recent times. Following a big jump in response to a strong quarter in the fall of last year, shares have been trading range-bound between $75 and $100 ever since. Shares are now trading towards the lower end of the range, near the $80 mark. This comes as the medical device complex at large is facing some...
ljubaphoto/E+ via Getty Images Shares of Globus Medical ( GMED ) have been trading flattish in recent times. Following a big jump in response to a strong quarter in the fall of last year, shares have been trading range-bound between $75 and $100 ever since. Shares are now trading towards the lower end of the range, near the $80 mark. This comes as the medical device complex at large is facing some headwinds, mostly in share price developments, as reported achievements remain strong. In November, I concluded that Globus was straightening its back after it successfully integrated the acquisition of NuVasive and Nevro, while organic growth in the higher single digits was compelling as well. Following a momentum run, shares traded at a 20 times earnings multiple, supported by a strong balance sheet and continued potential to derive more synergies. Over the past half year or so, shares have fallen by mid-single digits, in a raging bull market, as the business continues to perform fine, increasing appeal again after I trimmed my position last year. A Solid Start To The Year Early in May, Globus started the year on a strong note as the company reported a 27% increase in first-quarter sales to $760 million. Excluding the purchase of Nevro and its contribution, base revenues were up 13% and change, or 11% and change in constant currency terms. That is a strong achievement, and it is with real margin gains delivered upon. GAAP earnings of $123 million came in at $0.90 per share, with adjusted earnings up forty-four cents to $1.12 per share, as the adjustments look largely fair. The balance sheet is furthermore in pristine shape, with cash and equivalent holdings standing at $800 million, with no debt visible on the balance sheet. While confirming the full-year sales outlook at a midpoint of $3.20 billion, the company hiked the earnings guidance by thirty cents to $4.70-$4.80 per share, a substantial hike early in the year. Trading at $79 and change, equity trades at 16-17 tim...
JHVEPhoto/iStock Editorial via Getty Images Dozens of S&P 500 stocks have doubled in the past 12 months. A handful is up a whopping 900% or more. Among them is Western Digital ( WDC ). Shares of this Information Technology sector company have soared 915% since June 2025. That puts WDC as third-best in the S&P 500 over the past year. I think there are more gains to come. While ‘peak earnings’ is a ...
JHVEPhoto/iStock Editorial via Getty Images Dozens of S&P 500 stocks have doubled in the past 12 months. A handful is up a whopping 900% or more. Among them is Western Digital ( WDC ). Shares of this Information Technology sector company have soared 915% since June 2025. That puts WDC as third-best in the S&P 500 over the past year. I think there are more gains to come. While ‘peak earnings’ is a clear risk looking out many quarters, the growth-adjusted valuation is not all that high, while technicals and momentum clearly favor the bulls. I’ll outline the earnings-driven valuation case, then assess risks and opportunities on the chart. WDC Among the S&P 500's Hypergainers YoY Barchart Back in April, WDC reported a solid set of quarterly results. Its fiscal Q3 non-GAAP EPS of $2.72 topped the Wall Street consensus forecast of $2.39, while revenue of $3.34 billion, up 46% from the same period a year earlier, was a material $90 million beat. Margins were eye-popping, and the management team projected a long-term data storage growth rate of more than 25% compounded annually. It was a banner quarterly report, but shares dipped 0.7% in the session that followed, marking a second consecutive negative earnings reaction. Implied volatility is indeed very high on “Western Dig” right now, above 80%, while short interest has climbed to 8.6%. Looking back on the quarter that was, WDC reported strong Q3 numbers, with revenue reaching $3.3 billion and non-GAAP EPS tagging $2.72; both numbers were better than the company’s guidance. Driven heavily by demand in its Cloud sector (which comprised 89% of total revenue), the firm tallied a non-GAAP gross margin of 50.5% (a 1,040 basis point increase vs. Q3 2025) and generated $978 million in free cash flow. Western Dig fired on all cylinders, too, from both financial and shareholder-friendly perspectives. Operational milestones for the quarter included shipping 4.1 million units of its latest-generation ePMR, expanding stock buybacks by...
(Bloomberg) -- CBS News fired 60 Minutes correspondent Scott Pelley after the longtime journalist confronted his new boss at an internal meeting on Monday.Most Read from BloombergRussia Finance Officials Tell Putin War Spending Is UnaffordableTrump to Get Audit Immunity as $1.8 Billion Fund in DoubtTrump Begins Rebuilding His Tariff Wall Citing Forced LaborCanada Dips Into Technical Recession for ...
(Bloomberg) -- CBS News fired 60 Minutes correspondent Scott Pelley after the longtime journalist confronted his new boss at an internal meeting on Monday.Most Read from BloombergRussia Finance Officials Tell Putin War Spending Is UnaffordableTrump to Get Audit Immunity as $1.8 Billion Fund in DoubtTrump Begins Rebuilding His Tariff Wall Citing Forced LaborCanada Dips Into Technical Recession for First Time Since 2020TikTok Billionaire Overtakes Mukesh Ambani as Asia’s Second-Richest PersonPelle
Indonesian stocks slumped to their lowest level in five years while the rupiah reached another record low, underscoring investor concern that persistently high oil prices are straining the country’s finances. The benchmark Jakarta Composite Index plunged as much as 5.2% to the lowest since May 2021. Materials led the declines, with a subgauge of the sector tumbling more than 10%. The rupiah weaken...
Indonesian stocks slumped to their lowest level in five years while the rupiah reached another record low, underscoring investor concern that persistently high oil prices are straining the country’s finances. The benchmark Jakarta Composite Index plunged as much as 5.2% to the lowest since May 2021. Materials led the declines, with a subgauge of the sector tumbling more than 10%. The rupiah weakened about 0.5% against the dollar, leading losses in Asia, as Brent crude prices advanced for a third day. The moves come after data on Tuesday showed Indonesia’s trade surplus nearly vanished in April as soaring prices for imported oil and gas outpaced export gains. Consumer prices rose 3.08% in May from a year earlier, exceeding the median estimate in a Bloomberg survey of economists and moving further above the midpoint of Bank Indonesia’s 1.5%-3.5% target. Investor confidence in local assets has been waning, owing to concerns over fiscal slippage due to elevated oil prices, a potential MSCI Inc. market reclassification this month and risks of credit rating downgrades. Down about 32% in 2026, the JCI is already the worst performer this year among more than 90 global equity indexes tracked by Bloomberg . Concerns that Indonesia’s credit rating and outlook “might be downgraded due to higher risk of a widening fiscal deficit” are weighing on stocks, said Henry Wibowo , a former JPMorgan & Chase Co. strategist who co-founded Alphagate Capital in Jakarta. Weakness in the rupiah, which is approaching the 18,000-per dollar mark, is also adding to the pressure, he added. Worries about tighter government control of the nation’s key commodity sector have also weighed on investor sentiment in recent weeks. President Prabowo Subianto announced in May that the administration would take direct control of exports of some of Indonesia’s most important commodities.
A wanted director of a scandal-hit Hong Kong charity who fled the city is facing a sweeping 14-count civil lawsuit in the United States over an alleged multimillion-dollar property scheme that the plaintiff described as a “shell game”. In a complaint for damages and equitable relief seen by the South China Morning Post, developer Joseph Lee Daniell accused Jacob Lam Hay-sing, the founder and direc...
A wanted director of a scandal-hit Hong Kong charity who fled the city is facing a sweeping 14-count civil lawsuit in the United States over an alleged multimillion-dollar property scheme that the plaintiff described as a “shell game”. In a complaint for damages and equitable relief seen by the South China Morning Post, developer Joseph Lee Daniell accused Jacob Lam Hay-sing, the founder and director of the now-defunct Hong Kong charity, Christian Zheng Sheng Association, of defrauding him of...
More on GameStop Wall Street Lunch: EBay Rejects GameStop Takeover Proposal GameStop's 'Crazy Idea' To Buy EBay Isn't So Crazy, But It Is Risky eBay And GameStop: A Deal Made In Meme Heaven GameStop rallies after record Q1 operating income tally, new $2B buyback program GameStop Non-GAAP EPS of $0.30 beats by $0.14, revenue of $835.3M
More on GameStop Wall Street Lunch: EBay Rejects GameStop Takeover Proposal GameStop's 'Crazy Idea' To Buy EBay Isn't So Crazy, But It Is Risky eBay And GameStop: A Deal Made In Meme Heaven GameStop rallies after record Q1 operating income tally, new $2B buyback program GameStop Non-GAAP EPS of $0.30 beats by $0.14, revenue of $835.3M
(RTTNews) - Indian shares tumbled in early trade on Wednesday, with IT stocks coming under heavy selling pressure after the U.S.-listed shares of both Infosys and Wipro declined between 2.5 percent and 8 percent during the overnight trading session on Wall Street.
(RTTNews) - Indian shares tumbled in early trade on Wednesday, with IT stocks coming under heavy selling pressure after the U.S.-listed shares of both Infosys and Wipro declined between 2.5 percent and 8 percent during the overnight trading session on Wall Street.
格隆汇6月3日｜随着伊朗战争重新引发通胀，新兴市场央行正引领一波加息浪潮，其行动速度超过了大多数仍在按兵不动以评估经济影响的发达经济体央行。自2月底战事开始以来，至少有10个新兴市场和前沿市场的央行已加息，其中印尼、卢旺达、南非和斯里兰卡在过去两周收紧了政策。美国、欧元区、日本和加拿大的政策制定者一直按兵不动，而挪威和澳大利亚是少数加息的发达经济体。Allspring Global Investm...
格隆汇6月3日｜随着伊朗战争重新引发通胀，新兴市场央行正引领一波加息浪潮，其行动速度超过了大多数仍在按兵不动以评估经济影响的发达经济体央行。自2月底战事开始以来，至少有10个新兴市场和前沿市场的央行已加息，其中印尼、卢旺达、南非和斯里兰卡在过去两周收紧了政策。美国、欧元区、日本和加拿大的政策制定者一直按兵不动，而挪威和澳大利亚是少数加息的发达经济体。Allspring Global Investments高级投资组合经理比容表示：“新兴市场央行正在借鉴上一个全球紧缩周期的经验教训，当时许多央行先于发达市场同行采取行动应对疫情后的通胀冲击，并在价格压力缓解时对降息更加谨慎。”新兴市场央行还在收紧政策以支持其货币并阻止资本外流，预计还会有更多央行跟进。
Brandon Moser Elon Musk's SpaceX ( SPCX ) plans to price its IPO at $135 per share, raising ~$75B through the sale of about 555.6M shares, according to a Reuters report that cites sources familiar with the matter. The offering would value the company at roughly $1.75T, making it the largest IPO on record if completed as planned. The IPO is expected to consist entirely of newly issued shares, with ...
Brandon Moser Elon Musk's SpaceX ( SPCX ) plans to price its IPO at $135 per share, raising ~$75B through the sale of about 555.6M shares, according to a Reuters report that cites sources familiar with the matter. The offering would value the company at roughly $1.75T, making it the largest IPO on record if completed as planned. The IPO is expected to consist entirely of newly issued shares, with all proceeds going directly to SpaceX. Existing shareholders, including insiders and early investors, are not expected to sell shares as part of the offering, the report added. Elon Musk will be subject to a 366-day lock-up period following the IPO, preventing him from selling his SpaceX ( SPCX ) stake during that time and underscoring his long-term commitment to the company, the sources said. The company is expected to list on the Nasdaq under the ticker 'SPCX,' with trading potentially beginning as early as June 12, while the rocket and satellite communications company plans to expand its AI computing infrastructure and further develop its satellite network. SpaceX ( SPCX ) will start its investor roadshow on Thursday after holding early meetings with potential investors ahead of the IPO. The IPO is being led by Goldman Sachs, Morgan Stanley, BofA Securities, Citigroup, and J.P. Morgan, which are acting as joint book-runners on the deal. More on SpaceX SpaceX: Lessons From The Post-IPO Drawdowns Of Mega-Tech Royalty SpaceX: Mars Can Wait, So Can I Houston, We Have A Problem: SpaceX, Tesla, And The xAI Bailout Nobody Voted On SpaceX eyes $75B IPO, targeting record $1.75T valuation with greenshoe option Blue Origin setback gives SpaceX more breathing room in launch market
Jitendra Jadhav/iStock via Getty Images It is becoming increasingly uncomfortable to be bearish on Hinge Health ( HNGE ). With each passing quarter, the company seems to exceed expectations and add momentum to its growth story. Now, don't get me wrong, this stock has been a very volatile name, and it is not necessarily for the faint of heart. Just take a look at its 5-year price chart, and you wil...
Jitendra Jadhav/iStock via Getty Images It is becoming increasingly uncomfortable to be bearish on Hinge Health ( HNGE ). With each passing quarter, the company seems to exceed expectations and add momentum to its growth story. Now, don't get me wrong, this stock has been a very volatile name, and it is not necessarily for the faint of heart. Just take a look at its 5-year price chart, and you will see what I am talking about: Data by YCharts That being said, I firmly believe that this name is poised to stabilize and provide real shareholder value going forward. Let's discuss why. Bears Are Fighting a Battle That Doesn't Make Sense for This Name One of the things that bears often like to latch onto when discussing digital health companies is the idea that they are all the same. That is to say that they might have a story behind how they are going to change the world, but their financials remain questionable. This line of reasoning might make sense for a lot of other names, but it doesn't quite line up as a reasonable line of attack against Hinge Health. A lot of my reason for confidence in saying this is the fact that the company just reported some stellar earnings numbers. Revenues Surged to $182 Million This Quarter Daniel Perez, Co-Founder and CEO of Hinge Health, was quick to note in the Q1 2026 earnings release that revenues have surged: We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs, He then went on to say that as a result of those figures being well ahead of expectations, the company would raise its guidance: Based on this momentum, we 're raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%. Clearly, management has a lot to be proud of in terms of how operations are running. I also read this as ...